Exelixis Inc. buy BMO Capital Markets
Start price
30.10.24
/
50%
€30.68
Target price
30.10.25
€33.16
Performance (%)
7.99%
End price
31.10.25
€33.13
Summary
This prediction ended on 31.10.25 with a price of €33.13. With a performance of 7.99%, the BUY prediction by BMO_Capital_Markets for Exelixis Inc. closed with a slight gain. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Exelixis Inc. | -6.836% | -6.836% | 10.237% |
| iShares Core DAX® | -1.432% | 0.000% | 12.331% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.688% |
| iShares Nikkei 225® | 1.448% | 5.269% | 18.051% |
| iShares S&P 500 | 0.114% | -0.217% | 1.388% |
Comments by BMO_Capital_Markets for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) had its price target raised by analysts at BMO Capital Markets from $29.00 to $36.00. They now have an "outperform" rating on the stock.
Ratings data for EXEL provided by MarketBeat
In the thread Trading Exelixis Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten